ciprofloxacin has been researched along with cefotaxime in 304 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (9.87) | 18.7374 |
| 1990's | 60 (19.74) | 18.2507 |
| 2000's | 92 (30.26) | 29.6817 |
| 2010's | 94 (30.92) | 24.3611 |
| 2020's | 28 (9.21) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, HA; Beskid, G; Christenson, JG; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Rossman, PL; Wei, CC | 1 |
| Albrecht, HA; Beskid, G; Christenson, JG; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Wei, CC | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Miller, MJ; Möllmann, U; Nora, GP | 1 |
| Choi, TY; Pai, H; Seo, MR | 1 |
| Chen, YG; Du, XX; Li, LJ; Shen, P; Wei, ZQ; Yu, YS | 1 |
| Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
| Kwon, DH; Lu, CD | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
| Chen, YT; Lauderdale, TL; Liao, TL; Shiau, YR; Shu, HY; Su, IJ; Tsai, SF; Wu, KM; Yan, JJ | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Fung, CP; Hsieh, YP; Hu, WS; Lin, JF; Liu, CP; Yao, SM | 1 |
| Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
| Iredell, JR; Partridge, SR; Zong, Z | 1 |
| Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
| Adams-Haduch, JM; de Oliveira Garcia, D; Doi, Y; Freire, MP; Leite, D; Padoveze, MC; Paterson, DL; Silveira, FP; Szabo, D; Vaz, TM | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Liu, CY | 1 |
| Espedido, BA; Iredell, JR; Partridge, SR | 1 |
| Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q | 1 |
| Berçot, B; Nordmann, P; Poirel, L | 1 |
| Chang, FY; Chen, JH; Fung, CP; Lai, YK; Lin, CJ; Lin, JC; Ma, L; Siu, LK | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Asensi, MD; Gales, AC; Monteiro, J; Peirano, G; Santos, AF | 1 |
| Bengoechea, JA; Giménez, P; Llobet, E; March, C | 1 |
| Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
| Baraniak, A; Bedenic, B; Fiett, J; Gniadkowski, M; Jajic-Bencic, I; Literacka, E; Tonkic, M | 1 |
| Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH | 1 |
| Bartolomé, R; Coelho, A; González-López, JJ; Larrosa, MN; Lavilla, S; Prats, G | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Accogli, M; Caprioli, A; Carattoli, A; Cerquetti, M; Fortini, D; García-Fernández, A; Giufrè, M; Graziani, C; Luzzi, I | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Brémont, S; Courvalin, P; Daurel, C; Fiant, AL; Leclercq, R | 1 |
| Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY | 1 |
| Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
| Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP | 1 |
| Aquino, EE; León, CF; Otero, DM; Robledo, IE; Santana, JL; Santé, MI; Vázquez, GJ | 1 |
| Bisgaard, M; Bojesen, AM; Bortolaia, V; Guardabassi, L; Trevisani, M; Venturi, L | 1 |
| Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ | 1 |
| Harada, S; Ishii, Y; Saga, T; Tateda, K; Yamaguchi, K | 1 |
| Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
| Bialek, S; Chevalier, J; Davin, A; Lavigne, JP; Leflon-Guibout, V; Marcon, E; Moreau, R; Nicolas-Chanoine, MH; Pagès, JM | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Bae, IK; Jeong, SH; Kim, J; Lee, K; Suh, B; Yong, D | 1 |
| Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
| Bouhours, P; Burchak, ON; Denis, JN; Giglione, C; Guinchard, X; Jolivalt, C; Maigre, L; Maurin, M; Meinnel, T; Paris, JM; Pihive, EL; Schneider, D | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Franzyk, H; Frimodt-Møller, N; Jahnsen, RD | 1 |
| Maravić, A; Odžak, R; Skočibušić, M | 1 |
| Franzyk, H; Frimodt-Møller, N; Jahnsen, RD; Nielsen, HM; Sandberg-Schaal, A; Vissing, KJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
| Arya, G; Dalal, P; Kaur, M; Nimesh, S; Salunke, DB; Singh, R; Singla, P | 1 |
| Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D | 1 |
| Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
| Klein, CD; van Oosten, LN | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Ayyagari, A; Gulati, S; Kumar, L; Marwaha, RK; Prakash, D; Singhi, P; Singhi, S; Walia, BN | 1 |
| Johnson, DM; Jones, RN | 1 |
| Davidson, RJ; Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Dawson, SJ; White, LA | 1 |
| Bertasso, A; Georgopapadakou, NH; Pace, J | 1 |
| Mehta, S; Misra, S; Panigrahi, D; Thapa, BR | 1 |
| Balestrieri, GP; Baratto, G; di Stefano, O; Giustina, G; Rossi, M; Salvi, A | 1 |
| Albrecht, HA; Beskid, G; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, CM; McGarry, DH; Rossman, P; Siebelist, J | 1 |
| Koenig, G; Simon, DM; Trenholme, GM | 1 |
| Beskid, G; Chan, K; Cleeland, R; Keith, DD; McGarry, CM; Siebelist, J | 1 |
| Chan, KK; Christenson, JG; Cleeland, R; Dix-Holzknecht, B; Farrish, HH; Patel, IH; Specian, A | 1 |
| Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J | 1 |
| Gu, JW; Neu, HC | 1 |
| Jones, RN | 1 |
| Krcméry, V | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Adler, M; Hörnle, R; Orfanos, CE; Stadler, R; Wagner, J | 1 |
| Aulicino, TM; Berkowitz, LB; duBouchet, L; Gombert, ME; Macchia, RJ | 1 |
| Christensen, MM; Knes, J; Madsen, PO; Nelsen, KT | 1 |
| Bertasso, A; Chan, KK; Chapman, JS; Cleeland, R; Cummings, LM; Dix, BA; Georgopapadakou, NH; Keith, DD | 1 |
| Archambaud, M; Clave, D; Labau, E; Suc, C | 1 |
| del Rosal, PL; Gentry, LO; Ramirez, C; Ramirez-Ronda, CH; Rodriguez-Noriega, E; Thadepalli, H | 1 |
| Cox, CE | 1 |
| Beskid, G; Chan, K; Cleeland, R; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, DH; Unowsky, J | 1 |
| Bartmann, K; Tarbuc, R | 1 |
| Bertram, MA; Kelley, SG; Young, LS | 1 |
| Alkan, M; Berger, S; Mark, Z; Rubinstein, E; Samra, Y | 1 |
| Rahal, JJ; Simberkoff, MS | 1 |
| Boness, J; Marre, R; Schulz, E; Tietgen, K | 1 |
| Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C | 1 |
| Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Black, WA; Bowie, WR; Boyd, J; Chan, DG; Shaw, CE | 1 |
| DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
| Chin, NX; Figueredo, VM; Neu, HC; Novelli, A | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Ramirez-Ronda, C; Saavedra, S | 1 |
| Finch, R; Martin, J; Pilkington, R | 1 |
| Fasching, CE; Gerding, DN; Peterson, LR | 1 |
| Ramirez-Ronda, CH; Rivera-Vázquez, CR; Saavedra, S | 1 |
| Asper, R; Parish, LC | 1 |
| Huitrón-Ramírez, JA; Morales-Reyes, JJ; Pérez-Ruvalcaba, JA; Quintero-Pérez, NP; Rodríguez-Chagollán, JJ; Rodríguez-Noriega, E | 1 |
| Drusano, GL; Forrest, A; Plaisance, K; Standiford, HC; Tatem, B | 1 |
| Cheng, N; Chow, AW; Whiting, JL | 1 |
| Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
| Pohlod, DJ; Saravolatz, LD | 1 |
| Cavallo, JD; Chevalier, B; Meyran, M | 1 |
| Codeluppi, M; D'Andrea, L; De Rienzo, B; Guaraldi, G; Manicardi, G; Mongiardo, N; Mussini, C; Squadrini, F; Trenti, F | 1 |
| Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
| Jones, RN; Sanchez, ML | 1 |
| Bakst, CM; Loughlin, KA; Rybak, MJ | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA | 1 |
| Bion, JF; Crosby, HA; Elliott, TS; Penn, CW | 1 |
| Gant, VA; Phillips, I; Savidge, GF; Warnes, G | 1 |
| Bertasso, A; Georgopapadakou, NH | 1 |
| Davidson, RJ; Hoban, DJ; Karlowsky, JA; Zhanel, GG; Zieroth, SR | 1 |
| Benmessaoud, K; Nouvet, G | 1 |
| Blondeau, JM; Yaschuk, Y | 1 |
| Beghi, GF; Casalini, A; Cazzola, M; Consigli, GF; Fiorentini, F; Giura, R; Madonini, V; Paizis, G; Tonna, M; Vinciguerra, A | 1 |
| Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
| Briggs, RJ; Fabinyi, G; Kamarulzaman, A; Richards, MJ | 1 |
| Mann, RD; Pearce, GL; Wilton, LV | 1 |
| Gould, IM; Hobson, RP; MacKenzie, FM | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Fink, U; Reiser, M; Sauter, G; Seemann, M; Wintersperger, BJ | 1 |
| Amato, GM; Giuffrè, M; Manfrè, L; Morello, A | 1 |
| Gorby, GL; Phanucharas, JP | 1 |
| George, J; Morrissey, I | 1 |
| Badrinath, S; Rao, RS; Vijayalakshmi, N | 1 |
| Nettles, RE; Sexton, DJ | 1 |
| Breithaupt, A; Breithaupt, H; Gehrke, R; Kraemer, HJ | 1 |
| Dryden, M; Page, A; Sampson, M; Samuel, W; Shepherd, H | 1 |
| Chang, SC; Chen, YC; Fang, CT; Hsieh, WC; Hsueh, PR; Hung, CC; Luh, KT | 1 |
| Bhutta, ZA | 1 |
| Abo Rahmy, E | 1 |
| Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ | 1 |
| Casey, AT; Davies, AP; Hart, AJ; Stannard, AJ; Thompson, P | 1 |
| Bernhardt, H; Knoke, M; Schulz, K; Zimmermann, K | 1 |
| Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
| Peters, G; Schumacher-Perdreau, F | 1 |
| Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S | 1 |
| Caron, F | 1 |
| Bonvin, P; Dons-Jensen, H; Ejlertsen, T | 1 |
| Cox, CE; Echols, RM; Klimberg, IW; Kowalsky, SF; Malek, GH; Patterson, AL; Whalen, E | 1 |
| Keane, CT; McCarthy, ND; McConkey, SJ | 1 |
| Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM | 1 |
| Doré, P; Fauchère, JL; Ferrand, E; Grollier, G; Hira, M; Robert, R | 1 |
| Bullock, P; Price, EH; Workman, MR | 1 |
| Butkevich, OM; Vinogradova, TL | 1 |
| Phantumchinda, K; Suankratay, C; Tachawiboonsak, W; Wilde, H | 1 |
| Bohidar, NP; Garg, PK; Kapil, A; Khanna, S; Tandon, RK | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Alcalá, B; Arreaza, L; Salcedo, C; Vázquez, JA | 1 |
| Baliga, S; Prabha Adhikari, MR | 1 |
| Bal, AM; Ghadage, DP | 1 |
| Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
| Hong, M; Tong, MH; Yao, DM | 1 |
| Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
| Abad, C; Elcuaz, R; Ponce, G | 1 |
| Agrappi, C; Clerici, P; Melloni, P; Vasconi, E; Viganò, EF | 1 |
| Bingen, E; Bourrillon, A; Faye, A; Louzeau, C; Mariani-Kurkjian, P; Taha, MK | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 2 |
| Cheung, TK; Chu, MY; Chu, YW; Kam, KM; Ma, CH; Yung, RW | 1 |
| Chung, CH; Han, H; Hong, SP; Jang, SJ; Kim, DM; Kim, YG; Lym, Y | 1 |
| Biswal, M; Sharma, M; Taneja, N; Tarai, B | 1 |
| Guo, SM; Hsueh, PR; Jean, SS; Lee, YT | 1 |
| Empel, J; Hryniewicz, W; Kadłubowski, M; Skoczyńska, A | 1 |
| Bonato, M; Dal Negro, G; Sciuscio, D; Vandin, L | 1 |
| Cevikbaş, A; Erçağ, E; Erten, N; Göçer, P; Gürbüz, B; Gürer, US; Karan, A; Rayaman, E; Uzer, A | 1 |
| Caniça, M; Dias, R; Louro, D | 1 |
| Cheong, HJ; Jung, SJ; Kim, MJ; Kim, WJ; Park, CW; Sohn, JW; Song, JY | 1 |
| Garg, RK; Marak, RS; Ray, P; Sharma, J | 1 |
| Bukharin, OV; Chernikov, DA; Gritsenko, VA; Tret'iakov, AA | 1 |
| Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
| Majtán, J; Majtán, V; Majtánová, L; Xu, M | 1 |
| Cho, DT; Kang, HY; Kim, J; Kim, KY; Lee, JC; Lee, YC; Seol, SY | 1 |
| Bazin, C; Boytchev, I; Buffet, C; Choury, AD; Dhalluin-Venier, V; Farah, RB; Fritsch, J; Furlan, V; Massias, L; Pelletier, G; Prat, F | 1 |
| Gal, P; McPherson, C; Ransom, JL | 1 |
| Chang, CM; Chen, HM; Chuang, YC; Ko, WC; Lee, HC; Lee, NY; Wang, LR; Wu, CJ; Wu, JJ | 1 |
| Gospodarek, E; Sekowska, A; Wróblewska, J | 1 |
| Li, D; Liu, Q; Song, X; Xu, C; Yang, X; Zhang, J | 1 |
| Chander, J; Deep, A; Gupta, V; Kaistha, N; Mehta, M; Sarkar, BL; Singla, N | 1 |
| Ahmeti, S; Dika, A; Gashi, G; Gashi, M; Gashi, S; Raka, L | 1 |
| Carlile, GS; Elvy, J; Toms, AD | 1 |
| Monescillo Francia, A | 1 |
| Bournet, BS; Cattoen, C; Dehecq, C; Garnier, LD; Lemaire, X; Senneville, E; Yazdanpanah, Y | 1 |
| Jang, SJ; Kim, DM; Kim, SH; Lee, BK; Neupane, GP | 1 |
| Gierczyński, R; Jagielski, M; Piekarska, K; Szych, J; Wardak, S; Wilk, E; Zacharczuk, K; Zawidzka, E | 1 |
| Kim, DM; Kim, SH; Lee, BK; Neupane, GP | 1 |
| Cui, S; Ding, H; Hu, C; Jin, S; Li, J; Ma, Y; Ran, L; Zhang, Q | 1 |
| Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
| Del Prado, G; Naves, P; Ponte, C; Soriano, F | 1 |
| Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
| Fusté, E; Veiga-Crespo, P; Villa, TG; Viñas, M; Vinuesa, T | 1 |
| Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
| Rianthavorn, P | 1 |
| Pshenkina, NN | 1 |
| Gospodarek, E; Piecyk, K; Zalas-Wiecek, P | 1 |
| Wang, J; Wei, Y | 1 |
| Egesie, JO; Kashibu, E; Nwadioha, SI; Nwokedi, EO; Onwuezube, I | 1 |
| Chiu, SK; Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL; Yeh, KM | 1 |
| Chen, Q; Cui, S; Gu, Y; Li, F; Lin, L; Luo, Y; Pang, L; Wang, Y; Xu, X; Yang, B; Zhang, F; Zhou, G | 1 |
| Chae, JD; Gopal, R; Kim, YG; Lee, JH; Lee, SK; Park, Y; Seo, CH; Son, BK | 1 |
| Hur, JA; Kim, BN; Kim, ES; Kim, YK; Lee, CS; Lee, JH; Moon, C; Oh, WS; Park, KH; Park, SW | 1 |
| Choi, SM; Choy, HE; Jang, HC; Jung, SI; Kang, SJ; Kim, HK; Kim, SE; Kim, YR; Lee, TH; Park, KH; Rhee, JH; Ryu, PY | 1 |
| Frimodt-Møller, N; Hertz, FB; Løbner-Olesen, A | 1 |
| Božić, DD; Ćirković, I; Ivković, B; Milenković, M | 1 |
| Bertrand, S; Ceyssens, PJ; Mattheus, W; Vanhoof, R | 1 |
| Cui, S; Lin, L; Ren, X; Xu, X | 1 |
| Abdelsalam, M; Abu-Elala, N; Marouf, Sh; Setta, A | 1 |
| Bai, L; Cui, S; Guo, Y; Lan, R; Li, F; Xu, J; Zhang, D; Zhang, X | 1 |
| Chen, Q; Cui, S; He, Y; Hu, Y; Huang, J; Li, F; Liu, G; Wang, Y; Yang, B; Yu, H; Zhou, G | 1 |
| Choe, HS; Kim, HY; Lee, DS; Lee, SJ; Yoo, JM | 1 |
| Kostrzewa, M; Schubert, S; Sparbier, K | 1 |
| Bogdanová, K; Froning, JP; Havrdová, M; Hradilová, Š; Kilianová, M; Kolář, M; Kvítek, L; Panáček, A; Prucek, R; Röderová, M; Smékalová, M; Večeřová, R; Zbořil, R | 1 |
| Al Nafeesah, AS | 1 |
| Bai, L; Cui, S; Fanning, S; Gan, X; Hu, Y; Li, F; Wang, J; Xia, S; Xu, J; Yan, S; Zhang, X; Zhao, J | 1 |
| Guerin, MT; Jardine, CM; LeJeune, JT; McEwen, SA; Medhanie, GA; Pearl, DL; Schrock, J | 2 |
| Becker, K; Bletz, S; Böking, T; Harmsen, D; Kipp, F; Mellmann, A; Prior, K; Schultes, A | 1 |
| Bae, SR; Bae, WJ; Cho, YH; Choe, HS; Han, CH; Jang, H; Kim, HY; Kim, SW; Lee, DS; Lee, SJ; Park, SB; Yoo, JM; Yoon, BI | 1 |
| Chang, FY; Chang, SC; Chen, YS; Chuang, YC; Fung, CP; Huang, IW; Lai, JF; Lauderdale, TL; Lin, WP; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
| Jiu, Y; Khan, SB; Li, S; Meng, X; Sun, M; Wu, B; Zhou, R; Zhu, S; Zou, G | 1 |
| Cizek, A; Clark, AB; Dolejska, M; Ellis, JC; Jamborova, I; Literak, I; Papousek, I; Townsend, AK; Zurek, L | 1 |
| Amini, E; Askari, P; Ghannadkafi, M; Namaei, MH; Salehabadi, A; Yousefi, M; Ziaee, M | 1 |
| Daniel, P; Hai Nguyen, N; Sarter, S; Xuan Nguyen, NT | 1 |
| Charfeddine, I; Ghorbel, A; Maalej, F; Masmoudi, M; Mnejja, M; Sellami, M | 1 |
| Demirel, I; Kruse, R; Persson, K; Sahlberg Bang, C | 1 |
| Banerjee, A; Bhattacharya, G; Das, S; Dey, D | 1 |
| Feicht, S; Finney, S; Habing, G; Hutchinson, H; Masterson, M; Muñoz-Vargas, L | 1 |
| Cheng, G; Jiang, W; Kong, L; Lei, C; Liu, B; Shi, H; Wang, H; Wang, Y; Yang, X; Yang, Y; Zhang, A; Zhang, X | 1 |
| Almirante, B; Andreu, A; Bosch-Nicolau, P; Falcó, V; Len, O; Pigrau, C; Viñado, B | 1 |
| Easton, M; Howden, BP; Kirk, MD; Lane, CR; Strachan, J; Valcanis, M; Veitch, MG; Williamson, DA | 1 |
| Mohan, B; Sethuraman, N; Taneja, N; Verma, R | 1 |
| Bai, Y; Gan, X; He, YY; Hu, YJ; Li, FQ; Liu, C; Peng, ZX; Wang, MM; Wang, W; Wang, YR; Xu, J; Yan, SF | 1 |
| Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
| Abdalhamid, BA; Alabdulqader, NA; Aljindan, RY; Hassan, HA; Hussein, NE; Khoudair, HA; Shaikh, AY; Shorman, MA | 1 |
| Ahn, J; Jeon, G; Uddin, MJ | 1 |
| García Señán, A; Gil González, AB; González Buitrago, JM; Hernández Egido, S; Luis Reboredo, A; Muñoz Bellido, JL; Sánchez-Juanes, F | 1 |
| Bogdan, C; Eisenberger, D; Höller, C; Lehner-Reindl, V; Nickel, S; Valenza, G; Werner, M | 1 |
| Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
| Kim, CM; Kim, DM; Park, HR; Yun, NR | 1 |
| Jacqz-Aigrain, E; Leroux, S; Magréault, S; Storme, T; Touati, J | 1 |
| Lee, B; Lee, DG | 1 |
| Ahn, J; Dawan, J; Ding, T; Kim, B; Kim, JC; Uddin, MJ | 1 |
| Choi, SM; Darboe, KS; Jang, HC; Jung, SI; Kang, G; Kang, SJ; Kim, HK; Kim, SE; Kim, UJ; Kim, YR; Park, KH; Rhee, JH; Yu, Y | 1 |
| Dhara, L; Tripathi, A | 2 |
| Axelsson, C; Nilson, B; Rehnstam-Holm, AS | 1 |
| Assegu Fenta, D; Derese, B; Lemma, K; Tadele, H; Tadesse, BT | 1 |
| Aliseda Pérez De Madrid, D; Compains Silva, E; Heras Mulero, H; Mozo Cuadrado, M; Tabuenca Del Barrio, L | 1 |
| Al-Ajmi, D; Banu, S; Rahman, S | 1 |
| Bezmaternykh, KV; Oktyabrsky, ON; Smirnova, GV; Tyulenev, AV | 1 |
| Eckmanns, T; Feig, M; Kaspar, H; Kollas, C; Merle, R; Noll, I; Suwono, B; Tenhagen, BA; Weiser, AA; Zacher, B | 1 |
| Fukuda, A; Hirai, Y; Nakamura, H; Ogasawara, J; Umeda, K; Usui, M; Yamamoto, K | 1 |
| Buszewski, B; Król-Górniak, A; Pauter, K; Pomastowski, P; Szultka-Młyńska, M; Szumski, M | 1 |
| Carolan, JC; Margalit, A; Walsh, F | 1 |
| Dong, Y; Du, Q; Han, R; Shi, L; Sun, D; Teng, M; Wang, T; Wang, Y; Zhang, T; Zhang, Y; Zheng, G | 1 |
| Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
| Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
| Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
| Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y | 1 |
| Bai, L; Chen, S; Du, PC; Jia, HY; Lu, M; Wang, Y; Zhai, WS; Zhan, ZF | 1 |
| Baik, SK; Han, KH; Heo, J; Heo, NY; Jung, YK; Kang, SH; Kim, BI; Kim, HS; Kim, MY; Kim, TH; Kim, YS; Park, JY; Park, SY; Seo, YS; Sohn, JH; Suh, SJ; Um, SH; Yim, HJ; Yim, SY | 1 |
| Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
| Rishi, P; Sharma, A; Singh, R | 1 |
| Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
| Asai, T; Hara-Kudo, Y; Ikeda, T; Kuroda, M; Momose, Y; Ogawa, M; Ohya, K; Okamura, M; Sakata, R; Sasaki, Y; Uema, M; Watanabe, M; Yonemitsu, K | 1 |
| Adib, N; Afsharikhah, S; Bagheri, M; Ghanbarpour, R; Jajarmi, M; Mohseni, P | 1 |
| Henriques, I; Rodrigues, ET; Silva, I; Tacão, M | 1 |
| Gomi, R; Harada, H; Komakech, AJ; Matsuda, T; Matsumura, Y; Tanaka, M; Yamamoto, M | 1 |
5 review(s) available for ciprofloxacin and cefotaxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Gonorrhea; Guidelines as Topic; Humans; Male; Ofloxacin; Randomized Controlled Trials as Topic | 1994 |
Skull osteomyelitis due to Salmonella species: two case reports and review.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Osteomyelitis; Salmonella Infections; Salmonella typhimurium; Skull; Tomography, X-Ray Computed | 1996 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
16 trial(s) available for ciprofloxacin and cefotaxime
| Article | Year |
|---|---|
Intravenous ciprofloxacin versus cefotaxime prophylaxis during transurethral surgery.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Ciprofloxacin; Double-Blind Method; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Urethra | 1989 |
Single-dose preoperative prophylaxis in transurethral surgery. Ciprofloxacin versus cefotaxime.
Topics: Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Humans; Male; Middle Aged; Postoperative Complications; Premedication; Urethra | 1989 |
Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Ciprofloxacin; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Wound Infection | 1989 |
Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Premedication; Random Allocation; Urethra | 1989 |
Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
Topics: Adult; Bacteria; Cefotaxime; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Skin Diseases, Infectious | 1987 |
Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Humans; Infusions, Intravenous; Male; Middle Aged; Skin Diseases, Infectious; Therapeutic Equivalency | 1987 |
Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
Topics: Administration, Oral; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Random Allocation; Skin Diseases, Infectious | 1987 |
Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials as Topic; Diabetes Complications; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Skin Diseases, Infectious | 1987 |
Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.
Topics: Adult; Bacteria; Cefotaxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Injections, Intravenous; Male; Time Factors | 1987 |
Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Male | 1995 |
Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1995 |
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Female; HIV-1; Humans; Incidence; Injections, Intramuscular; Male; Metronidazole; Middle Aged; Penicillin G Benzathine; Prevalence; Sexual Behavior; Sexually Transmitted Diseases; Single-Blind Method; Uganda | 1998 |
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bacteriuria; Cefotaxime; Cephalosporins; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Prostatectomy | 1999 |
The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
Topics: Adult; Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Candida albicans; Cefotaxime; Ciprofloxacin; Doxycycline; Humans; Neutrophils; Phagocytosis; Rifampin; Zinc | 2006 |
Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile; Bilirubin; Cefotaxime; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Humans; Male; Middle Aged; Prospective Studies | 2008 |
Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ascites; Bacterial Infections; Cefotaxime; Ceftriaxone; Ciprofloxacin; End Stage Liver Disease; Humans; Liver Cirrhosis; Middle Aged; Peritonitis; Prospective Studies; Severity of Illness Index; Young Adult | 2023 |
283 other study(ies) available for ciprofloxacin and cefotaxime
| Article | Year |
|---|---|
Dual-action cephalosporins: cephalosporin 3'-quinolone carbamates.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli; Mice; Pseudomonas aeruginosa; Spectrophotometry, Infrared; Staphylococcus aureus; Streptococcus pneumoniae | 1991 |
Dual-action cephalosporins incorporating a 3'-tertiary-amine-linked quinolone.
Topics: beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Nitrogen; Quinolines; Structure-Activity Relationship | 1994 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
Topics: Anti-Bacterial Agents; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure | 2006 |
Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2007 |
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Hospitals, University; Humans; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids | 2007 |
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic | 2007 |
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polymerase Chain Reaction | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
Topics: Aeromonas; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Salmonella; Salmonella Infections; Taiwan; Tetracycline Resistance; Tigecycline; Vibrio; Vibrio Infections | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Taiwan | 2009 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
Topics: beta-Lactamases; Brazil; Carbapenems; Klebsiella pneumoniae | 2009 |
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane Proteins; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Klebsiella pneumoniae; Mutation | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Escherichia coli; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids | 2009 |
First detection of plasmid-encoded blaOXY beta-lactamase.
Topics: beta-Lactamases; Blotting, Southern; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Poultry; Poultry Diseases; Quinolones; Salmonella enterica | 2009 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacter; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Tigecycline | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea | 2010 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial | 2010 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors | 2010 |
Detection of KPC in Acinetobacter spp. in Puerto Rico.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Puerto Rico | 2010 |
High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks.
Topics: Amplified Fragment Length Polymorphism Analysis; Animals; beta-Lactamases; Cephalosporin Resistance; Chickens; Disease Reservoirs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genes, Bacterial; Genetic Variation; Humans; Italy; Microbial Sensitivity Tests; Plasmids | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests | 2010 |
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
Topics: beta-Lactamases; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Klebsiella pneumoniae; Molecular Sequence Data; Polymerase Chain Reaction; Proteus mirabilis; Salmonella typhimurium | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Biological Transport; Caenorhabditis elegans; Drug Resistance, Bacterial; Ertapenem; Klebsiella pneumoniae; Reverse Transcriptase Polymerase Chain Reaction; Virulence | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Porins; Reverse Transcriptase Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Indoles; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Circular Dichroism; Drug Resistance, Multiple, Bacterial; Drug Stability; Enterobacteriaceae; Escherichia coli; HeLa Cells; Humans; Microbial Sensitivity Tests; Peptidomimetics; Protein Structure, Secondary; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Unilamellar Liposomes | 2012 |
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Multiple; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imidazoles; Microbial Sensitivity Tests; Mycoses; Oximes | 2013 |
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Proliferation; Circular Dichroism; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Liposomes; Microbial Sensitivity Tests; Molecular Structure; Neoplasms; Peptidomimetics; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial Infections.
Topics: Anti-Bacterial Agents; Bile Acids and Salts; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline | 2019 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
Topics: Anti-Bacterial Agents; Escherichia coli; Machine Learning; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2020 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Multi-drug-resistant Salmonella typhi--a need for therapeutic reappraisal.
Topics: Cefotaxime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Infant; Male; Salmonella typhi; Typhoid Fever | 1992 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli.
Topics: Cefotaxime; Cerebrospinal Fluid; Ciprofloxacin; Escherichia coli; Gentamicins; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1992 |
Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin.
Topics: Adult; Cefotaxime; Ciprofloxacin; Endocarditis, Bacterial; Haemophilus Infections; Humans; Male; Microbial Sensitivity Tests; Netilmicin | 1992 |
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cell Membrane Permeability; Cephalosporins; Ciprofloxacin; Coliphages; DNA Replication; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Porins | 1991 |
Treatment of enteric fever--what next?
Topics: Ampicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; India; Male; Salmonella typhi; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1991 |
Septic polyarthritis in chronic tophaceous gout.
Topics: Ampicillin; Arthritis, Infectious; Cefotaxime; Ciprofloxacin; Gout; Humans; Male; Middle Aged; Pneumococcal Infections | 1991 |
In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Meningitis; Mice; Microbial Sensitivity Tests; Pneumonia | 1991 |
Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Humans; Imipenem; Leukemia, Monocytic, Acute; Leukocytes, Mononuclear; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Evaluation, Preclinical; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Klebsiella pneumoniae; Meningitis; Mice; Neutropenia; Penicillin Resistance; Pneumonia; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Time Factors | 1990 |
Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Dogs; Fleroxacin; Fluoroquinolones; Humans; Injections, Intravenous; Mice; Papio; Rats; Species Specificity | 1990 |
Cephalosporin 3'-quinolone esters with a dual mode of action.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests | 1990 |
In vitro activity of Ro 24-6392, a novel ester-linked co-drug combining ciprofloxacin and desacetylcefotaxime.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests | 1990 |
[Dual cephalosporins--a return of fixed combinations of antibiotics?].
Topics: Anti-Infective Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Fleroxacin; Fluoroquinolones | 1990 |
Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
Topics: Anti-Infective Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
[Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain].
Topics: Adolescent; Adult; Cefotaxime; Ciprofloxacin; Epididymitis; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin Resistance; Spectinomycin; Urethritis | 1989 |
Mode of action of the dual-action cephalosporin Ro 23-9424.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Ciprofloxacin; DNA Replication; DNA, Bacterial; Enterobacter; Escherichia coli; Fleroxacin; Fluoroquinolones; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1989 |
[Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Topics: Cefotaxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Sulbactam | 1989 |
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pseudomonas | 1989 |
Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Quinolines | 1985 |
Activity of ciprofloxacin against resistant clinical isolates.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolines | 1986 |
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azlocillin; Bacteria; Cefamandole; Cefotaxime; Cefsulodin; Ciprofloxacin; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Mezlocillin; Penicillin Resistance; Proteus; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Shigella; Staphylococcus | 1986 |
Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
Topics: Amikacin; Cefotaxime; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Humans; Kanamycin; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus | 1986 |
[Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats].
Topics: Acute Disease; Animals; Anti-Infective Agents, Urinary; Cefotaxime; Chronic Disease; Ciprofloxacin; Escherichia coli Infections; Female; Pyelonephritis; Quinolines; Rats; Rats, Inbred Strains | 1986 |
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins | 1986 |
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits | 1986 |
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Chlamydia trachomatis; Ciprofloxacin; Female; Fluoroquinolones; Gardnerella vaginalis; Genitalia; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1986 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Topics: Anti-Bacterial Agents; Cefotaxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Imipenem; Magnesium; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Quinolones; Thienamycins | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
Topics: Amikacin; Animals; Azlocillin; Bacterial Infections; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Penicillin Resistance; Rabbits | 1987 |
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.
Topics: Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Ciprofloxacin; Drug Interactions; Drug Synergism; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Metronidazole; Mezlocillin | 1987 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin | 1984 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
Non-typhoid Salmonella subdural empyema in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Brain Abscess; Cefotaxime; Chloramphenicol; Ciprofloxacin; Empyema, Subdural; Humans; Male; Meningitis, Bacterial; Salmonella; Salmonella Infections; Serotyping; Tomography, X-Ray Computed | 1995 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure | 1994 |
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
Antibiotic-induced release of endotoxin from bacteria in vitro.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Endotoxins; Enterobacter cloacae; Escherichia coli; Humans; Limulus Test; Lipopolysaccharides; Microscopy, Electron, Scanning; Piperacillin; Silver Staining; Tobramycin | 1994 |
The application of flow cytometry to the study of bacterial responses to antibiotics.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Escherichia coli; Flow Cytometry; Gentamicins; Humans; Microspheres | 1993 |
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.
Topics: Amines; Anti-Infective Agents; Bacterial Proteins; Carrier Proteins; Cefotaxime; Ceftriaxone; Cell Nucleus; Cephalosporins; Ciprofloxacin; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1993 |
In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth.
Topics: Cefotaxime; Cerebrospinal Fluid; Ciprofloxacin; Culture Media; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests | 1993 |
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Disease Outbreaks; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Rifampin | 1995 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome | 1996 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Costs and Cost Analysis; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Scotland | 1996 |
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.
Topics: Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Evaluation Studies as Topic; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sensitivity and Specificity; Tetracycline | 1996 |
[Disseminated liver abscesses in yersiniosis: diagnosis by ultrasound and spiral CT].
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Female; Humans; Liver Abscess; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Yersinia Infections | 1996 |
[Discitis in childhood: integrated neuroradiological imaging in diagnosis and follow-up study of one case].
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Discitis; Female; Humans; Lumbosacral Region; Magnetic Resonance Imaging; Teicoplanin | 1997 |
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Fallopian Tubes; Female; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Organ Culture Techniques | 1997 |
The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Fluoroquinolones; Levofloxacin; Ofloxacin; Quinolones; Streptococcus pneumoniae | 1997 |
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Furazolidone; Gentamicins; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; O Antigens; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections | 1997 |
Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Cefotaxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Lens, Crystalline; Ofloxacin | 1997 |
Spinal abscess of Haemophilus paraphrophilus. A case report.
Topics: Abscess; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Haemophilus; Haemophilus Infections; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Middle Aged; Spinal Diseases | 1997 |
Haemophilus aphrophilus bacteraemia complicated with vertebral osteomyelitis and spinal epidural abscess in a patient with liver cirrhosis.
Topics: Abscess; Aged; Bacteremia; Cefotaxime; Ciprofloxacin; Epidural Space; Female; Haemophilus; Haemophilus Infections; Histocytochemistry; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Osteomyelitis; Spinal Diseases | 1997 |
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed | 1997 |
Perioperative antibiotic prophylaxis in abdominal surgery for hernia repair: retrospective study of 1,524 consecutive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Herniorrhaphy; Humans; Male; Middle Aged; Pefloxacin; Retrospective Studies; Surgical Wound Infection; Treatment Outcome | 1998 |
Haemophilus paraphrophilus; a rare cause of intracranial abscess.
Topics: Adult; Brain; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Haemophilus; Haemophilus Infections; Humans; Male; Stereotaxic Techniques; Tomography, X-Ray Computed | 1998 |
Influence of ciprofloxacin and other antimicrobial drugs on different Escherichia coli strains in continuous-flow cultures under aerobic and anaerobic conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Culture Media; Escherichia coli; Feces; Gentamicins; Mezlocillin; Penicillins | 1998 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Brain abscess caused by Salmonella enteritidis in an immunocompetent adult patient: successful treatment with cefotaxime and ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Enteritis; Humans; Immunocompetence; Male; Salmonella Infections | 1998 |
Primary peritonitis due to nonenteric salmonellae.
Topics: Adolescent; Aged; Amoxicillin; Cefotaxime; Ciprofloxacin; Clavulanic Acid; Fatal Outcome; Humans; Male; Metronidazole; Peritonitis; Salmonella; Salmonella Infections; Salmonella typhimurium; Treatment Outcome | 1999 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden | 1999 |
Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria, Anaerobic; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Prevotella; Retrospective Studies; Treatment Outcome | 1999 |
Salmonella meningitis and multiple cerebral abscesses in an infant.
Topics: Amoxicillin; Ampicillin; Brain Abscess; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Bacterial; Metronidazole; Salmonella enteritidis; Salmonella Infections | 1999 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
Non-serogroup O:1 Vibrio cholerae bacteremia and cerebritis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Cholera; Ciprofloxacin; Humans; Male; Meningitis, Bacterial; Vibrio cholerae | 2001 |
Incidence, spectrum and antibiotic sensitivity pattern of bacterial infections among patients with acute pancreatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pancreatitis, Acute Necrotizing; Pseudomonas Infections | 2001 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
What about antibiotic resistance in Neisseria lactamica?
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Neisseria; Neisseriaceae Infections; Penicillins; Rifampin | 2002 |
Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
Topics: Adolescent; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2002 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Norfloxacin; Penicillins; Prevalence; Retrospective Studies; Salmonella; Salmonella Infections; Sepsis; Time Factors | 2002 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
[Antibiotic resistance and the detection in respiratory tract isolate of Moraxella catarrhalis].
Topics: Aged; Cefotaxime; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Cough; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Pharynx | 2003 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |
Early vascular graft infection due to Yersinia enterocolitica after repair of an abdominal aortic aneurysm.
Topics: Aged; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cefotaxime; Ciprofloxacin; Combined Modality Therapy; Humans; Male; Prosthesis-Related Infections; Yersinia enterocolitica; Yersinia Infections | 2004 |
Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Bacteria; Bacteriological Techniques; Blood; Cefotaxime; Ciprofloxacin; Culture Media; Enterococcus faecalis; Escherichia coli; Gentamicins; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
[Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Female; Follow-Up Studies; Fosfomycin; Humans; Infant; Male; Meningitis, Meningococcal; Meningococcal Infections; Neisseria meningitidis; Pericarditis; Time Factors; Treatment Outcome; Uveitis | 2005 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin | 2004 |
Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Hong Kong; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Salmonella enteritidis; Sequence Homology, Amino Acid | 2005 |
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Vibrio vulnificus | 2005 |
Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2005 |
Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Middle Aged; Psoas Abscess; Recurrence; Salmonella enterica; Salmonella Infections; Spondylitis; Treatment Outcome; Uremia | 2005 |
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Haemophilus influenzae type b; Humans; Meningitis; Microbial Sensitivity Tests; Poland; Rifampin | 2005 |
Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system.
Topics: Animals; Cefazolin; Cefotaxime; Ciprofloxacin; Colony-Forming Units Assay; Doxorubicin; Granulocytes; Hematopoietic Stem Cells; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Valproic Acid; Zidovudine | 2006 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Female; Gastrointestinal Hemorrhage; Humans; Kidney Diseases; Klebsiella pneumoniae; Male; Middle Aged; Multivariate Analysis; Peritonitis; Prognosis; Shock; Survival Rate; Time Factors | 2006 |
Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Topics: Biomarkers; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi | 2006 |
[Taxonomic spectrum and antibiotic resistance of Enterobacteriaceae isolated from bile of patients with cholangitis].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Amoxicillin; Anti-Bacterial Agents; Bile; Cefazolin; Cefotaxime; Cholangitis; Chronic Disease; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Gentamicins; Humans; Male; Middle Aged | 2006 |
In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biofilms; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polysaccharides, Bacterial; Salmonella Infections; Salmonella Phages; Salmonella typhimurium; Slovakia; Spectrophotometry | 2008 |
Distribution of conjugative-plasmid-mediated 16S rRNA methylase genes among amikacin-resistant Enterobacteriaceae isolates collected in 1995 to 1998 and 2001 to 2006 at a university hospital in South Korea and identification of conjugative plasmids mediat
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Hospitals, University; Humans; Korea; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2008 |
Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Citrobacter koseri; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Infant, Premature | 2008 |
In vitro combination of cefotaxime and ciprofloxacin against non-typhoid salmonellae.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Synergism; Humans; Microbial Sensitivity Tests; Salmonella | 2009 |
[Influence of sub-mics of selected antibiotics on hydrophobic and adhering properties of Klebsiella pneumoniae strains isolated from urine samples].
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Hydrophobic and Hydrophilic Interactions; Klebsiella pneumoniae; Microbial Sensitivity Tests; Species Specificity; Tetracycline; Urine | 2008 |
[Biological and molecular characteristics of a cat-borne Bartonella clarridgeiae].
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Bartonella; Cats; Cefotaxime; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Microbial Sensitivity Tests; Phylogeny; Random Amplified Polymorphic DNA Technique; Rifampin; RNA, Ribosomal, 16S | 2009 |
Epidemiology & antibiograms of Vibrio cholerae isolates from a tertiary care hospital in Chandigarh, north India.
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Cholera; Ciprofloxacin; Drug Resistance; Female; Furazolidone; Gentamicins; Humans; India; Male; Microbial Sensitivity Tests; Retrospective Studies; Serotyping; Sex Factors; Vibrio cholerae O1 | 2009 |
The impact of diagnostic delay on the course of septic shock caused by extended-spectrum-beta- lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Escherichia coli; Escherichia coli Proteins; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Shock, Septic; Thienamycins; Time Factors | 2009 |
Salmonella infection of a total knee replacement.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Cefotaxime; Ciprofloxacin; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Prosthesis Failure; Prosthesis-Related Infections; Reoperation; Salmonella enterica; Salmonella Infections | 2010 |
[Spontaneous bacterial peritonitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Humans; Ofloxacin; Peritonitis; Primary Prevention; Renal Insufficiency; Secondary Prevention | 2009 |
Spondylodiscitis and an aortic aneurysm due to Campylobacter coli.
Topics: Aged; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteremia; Campylobacter coli; Campylobacter Infections; Cefotaxime; Ciprofloxacin; Discitis; Drug Therapy, Combination; Gentamicins; Humans; Male; Radiography | 2010 |
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Typhoid Fever | 2010 |
[Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland].
Topics: Adult; Aged; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Poland; Species Specificity | 2010 |
In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B.
Topics: Bacterial Proteins; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Salmonella paratyphi A | 2010 |
Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China.
Topics: Agriculture; Animals; beta-Lactamases; Cefotaxime; China; Ciprofloxacin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Integrons; Microbial Sensitivity Tests; Poultry; Swine | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Differences in the in vitro susceptibility of planktonic and biofilm-associated Escherichia coli strains to antimicrobial agents.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Oxazines; Plankton; Xanthenes | 2010 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
Synergism between outer membrane proteins and antimicrobials.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefotaxime; Chlorocebus aethiops; Ciprofloxacin; Clindamycin; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Tetracycline; Vero Cells | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
Progression and resolution of acute focal bacterial nephritis.
Topics: Acute Disease; Cefotaxime; Child, Preschool; Ciprofloxacin; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Follow-Up Studies; Humans; Monitoring, Physiologic; Nephritis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler | 2011 |
[Influence of perftoran on pharmacokinetics of hydrophilic drugs].
Topics: Animals; Blood Substitutes; Cefazolin; Cefotaxime; Ciprofloxacin; Drug Interactions; Fluorocarbons; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Male; Pentoxifylline; Rabbits | 2011 |
Influence of subinhibitory concentrations of cefotaxime, imipenem and ciprofloxacin on adhesion of Escherichia coli strains to polystyrene.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Cefotaxime; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Microbial Sensitivity Tests; Polystyrenes | 2011 |
First detection of VIM-4 metallo-β-lactamase-producing Citrobacter freundii in China.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; China; Ciprofloxacin; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Respiratory Tract Infections; Thienamycins | 2013 |
Bacterial isolates from cerebrospinal fluid of children with suspected acute meningitis in a Nigerian tertiary hospital.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cerebrospinal Fluid; Child; Child, Preschool; Ciprofloxacin; Enterococcus; Escherichia coli; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Meningitis, Escherichia coli; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Nigeria; Retrospective Studies; Streptococcus agalactiae; Tertiary Care Centers | 2013 |
National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefotaxime; Cefoxitin; Ceftazidime; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2013 |
Prevalence and characterization of cefotaxime and ciprofloxacin co-resistant Escherichia coli isolates in retail chicken carcasses and Ground Pork, China.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Chickens; China; Ciprofloxacin; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; Meat Products; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Swine | 2014 |
Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Keratinocytes; Ketolides; Microbial Sensitivity Tests | 2014 |
Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Middle Aged; Multivariate Analysis; Prospective Studies; Pyelonephritis; Republic of Korea | 2014 |
In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefotaxime; Cell Death; Ciprofloxacin; Colony Count, Microbial; Drug Therapy, Combination; Female; HeLa Cells; Humans; Mice, Inbred BALB C; Microbial Sensitivity Tests; Sepsis; Survival Analysis; Time Factors; Transcription, Genetic; Vibrio Infections; Vibrio vulnificus | 2014 |
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Topics: Amdinocillin; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Clindamycin; Dicloxacillin; Escherichia coli; Gram-Positive Bacteria; Meropenem; Mice; Penicillins; Thienamycins | 2014 |
Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chalcones; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Ciprofloxacin; Drug Synergism; Gentamicins; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Statistics, Nonparametric; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Trends in serotype distribution and antimicrobial susceptibility in Salmonella enterica isolates from humans in Belgium, 2009 to 2013.
Topics: Bacterial Proteins; Belgium; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections; Serogroup | 2015 |
[Prevalence and characterization of cefotaxime and ciprofloxacin co-resistant Escherichia coli isolates in retail chicken carcasses].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Chickens; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Meat; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones; Risk Assessment | 2014 |
Comparative analysis of virulence genes, antibiotic resistance and gyrB-based phylogeny of motile Aeromonas species isolates from Nile tilapia and domestic fowl.
Topics: Aeromonas caviae; Aeromonas hydrophila; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Chickens; Cichlids; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Feces; Fish Diseases; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Poultry Diseases; Sulbactam; Virulence Factors | 2015 |
Prevalence of Salmonella Isolates from Chicken and Pig Slaughterhouses and Emergence of Ciprofloxacin and Cefotaxime Co-Resistant S. enterica Serovar Indiana in Henan, China.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Cefotaxime; Chickens; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation; Plasmids; Prevalence; Salmonella; Serogroup; Swine | 2015 |
[Epidemic condition and molecular subtyping of ciprofloxacin and cefotaxime co-resistant Salmonella Indiana isolated from retail chicken carcasses in six provinces, China].
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Chickens; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Food Contamination; Food Microbiology; Meat; Salmonella; Serotyping | 2015 |
Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Ciprofloxacin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
MBT-ASTRA: A suitable tool for fast antibiotic susceptibility testing?
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tobramycin | 2016 |
Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gene Expression; Gentamicins; Klebsiella pneumoniae; Meropenem; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Thienamycins | 2016 |
Nontyphoidal Salmonella septic arthritis of the elbow in a healthy infant.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Ciprofloxacin; Elbow Joint; Female; Humans; Infant; Salmonella Infections; Saudi Arabia; Treatment Outcome | 2015 |
Emergence and Diversity of Salmonella enterica Serovar Indiana Isolates with Concurrent Resistance to Ciprofloxacin and Cefotaxime from Patients and Food-Producing Animals in China.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; China; Ciprofloxacin; DNA Topoisomerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Feces; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Salmonella; Salmonella enterica; Salmonella Infections, Animal | 2016 |
Spatial Clustering of Escherichia coli with Reduced Susceptibility to Cefotaxime and Ciprofloxacin among Dairy Cattle Farms Relative to European Starling Night Roosts.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cefotaxime; Ciprofloxacin; Cluster Analysis; Dairying; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Farms; Ohio; Starlings | 2017 |
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Cross Infection; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Genome, Bacterial; Gram-Positive Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Staphylococcal Infections; Vancomycin-Resistant Enterococci | 2016 |
Role of age and sex in determining antibiotic resistance in febrile urinary tract infections.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Humans; Incidence; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Retrospective Studies; Sex Factors; Urinary Tract Infections; Young Adult | 2016 |
The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Population Surveillance; Taiwan; Urine; Young Adult | 2016 |
On-farm starling populations and other environmental and management factors associated with the presence of cefotaxime and ciprofloxacin resistant E. coli among dairy cattle in Ohio.
Topics: Animal Distribution; Animals; Anti-Bacterial Agents; Cattle; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Farms; Feces; Logistic Models; Ohio; Starlings | 2016 |
Phenotypic and Genotypic Resistance of Salmonella Isolates from Healthy and Diseased Pigs in China During 2008-2015.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Cefotaxime; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Farms; Genotype; Phenotype; Salmonella; Salmonella Infections, Animal; Serogroup; Swine; Swine Diseases; Tetracycline | 2017 |
Plasmid-mediated resistance to cephalosporins and quinolones in Escherichia coli from American crows in the USA.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Bird Diseases; Cefotaxime; Ciprofloxacin; Crows; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; United States | 2017 |
First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Ciprofloxacin; Clone Cells; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression; Gentamicins; Humans; Iran; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Prevalence; Virulence Factors | 2017 |
Detection of molecular changes induced by antibiotics in Escherichia coli using vibrational spectroscopy.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Escherichia coli; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Vibration | 2017 |
[The complicated acute bacterial parotitis in adults].
Topics: Acute Disease; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Female; Humans; Metronidazole; Parotitis; Self Medication; Streptococcal Infections; Tomography, X-Ray Computed; Viridans Streptococci | 2017 |
Global gene expression profiling and antibiotic susceptibility after repeated exposure to the carbon monoxide-releasing molecule-2 (CORM-2) in multidrug-resistant ESBL-producing uropathogenic Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Cefotaxime; Cell Death; Cell Line; Ciprofloxacin; Cytokines; Drug Resistance, Multiple, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Ontology; Humans; Kidney; Microbial Sensitivity Tests; Microbial Viability; Movement; Organometallic Compounds; Phenotype; Real-Time Polymerase Chain Reaction; Transcription, Genetic; Trimethoprim; Uropathogenic Escherichia coli; Virulence | 2017 |
Exposure to sub-inhibitory concentrations of gentamicin, ciprofloxacin and cefotaxime induces multidrug resistance and reactive oxygen species generation in meticillin-sensitive Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Reactive Oxygen Species; Staphylococcus aureus | 2017 |
Prevalence and Transmission of Antimicrobial Resistance in a Vertically Integrated Veal Calf Production System.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Cattle; Cefepime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Feces; Food Contamination; Food Microbiology; Food Supply; Foodborne Diseases; Genes, Bacterial; Male; Prospective Studies; Red Meat; United States | 2017 |
Emergence of Salmonella enterica serovar Indiana and California isolates with concurrent resistance to cefotaxime, amikacin and ciprofloxacin from chickens in China.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Chickens; China; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing; Quinolones; RNA, Ribosomal, 16S; Salmonella enterica | 2017 |
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Empirical Research; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2017 |
Increasing Antimicrobial Resistance in Nontyphoidal Salmonella Isolates in Australia from 1979 to 2015.
Topics: Anti-Bacterial Agents; Australia; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections; Serogroup | 2018 |
Speciation, clinical profile & antibiotic resistance in
Topics: Adolescent; Adult; Aeromonas; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Female; Humans; India; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Retrospective Studies; Tertiary Care Centers; Young Adult | 2017 |
[Serotype distribution and antimicrobial resistance of
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Chickens; China; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Meat; Microbial Sensitivity Tests; Salmonella; Serogroup | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
First description of plasmid mediated quinolone resistance genes in salmonella isolates from Saudi hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; DNA Topoisomerases; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella; Salmonella Infections; Saudi Arabia; Young Adult | 2018 |
Variability in the Adaptive Response of Antibiotic-Resistant Salmonella Typhimurium to Environmental Stresses.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Environment; Gene Expression Regulation, Bacterial; Genotype; Hot Temperature; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Osmotic Pressure; Phenotype; Salmonella typhimurium | 2019 |
Summation of peaks and L34 ribosomal protein in the presence and absence of antibiotics enables susceptibility testing using MALDI-TOF mass spectrometry in 2h from Escherichia coli-positive blood cultures.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Blood Culture; Cefotaxime; Ciprofloxacin; Escherichia coli; Humans; Microbial Sensitivity Tests; Ribosomal Proteins; Software; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2019 |
First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Germany; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones; Serogroup; Virulence Factors; Young Adult | 2019 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
Identifying the mechanism underlying treatment failure for Salmonella Paratyphi A infection using next-generation sequencing - a case report.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Male; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Treatment Failure | 2019 |
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; Cefotaxime; Child; Child, Preschool; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Limit of Detection; Male; Meropenem; Metronidazole; Pediatrics; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Synergistic antibacterial activity of gold nanoparticles caused by apoptosis-like death.
Topics: Anti-Bacterial Agents; Apoptosis; Cefotaxime; Ciprofloxacin; Drug Synergism; Gold; Metal Nanoparticles; Reactive Oxygen Species; Salmonella | 2019 |
Assessment of antibiotic resistance in bacteriophage-insensitive Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; Cefotaxime; Cephalothin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Klebsiella pneumoniae; Levofloxacin; Phage Therapy; Quinolones | 2019 |
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Survival Analysis; Tigecycline; Vibrio Infections; Vibrio vulnificus | 2019 |
Cinnamaldehyde: a compound with antimicrobial and synergistic activity against ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
Topics: Acrolein; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins | 2020 |
Rapid detection of antibiotic resistance in positive blood cultures by MALDI-TOF MS and an automated and optimized MBT-ASTRA protocol for
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2020 |
Antimicrobial sensitivity profile and bacterial isolates among suspected pyogenic meningitis patients attending at Hawassa University Hospital: Cross-sectional study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Penicillins; Phylogeny; Young Adult | 2020 |
The use of eugenol in combination with cefotaxime and ciprofloxacin to combat ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Eugenol; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Quinolones | 2020 |
Haemophilus Influenzae Endogenous Endophthalmitis in an Immunocompetent Host.
Topics: Adolescent; Anti-Bacterial Agents; Cataract Extraction; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Endotamponade; Eye Infections, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Immunocompromised Host; Infusions, Intravenous; Intravitreal Injections; Male; Slit Lamp Microscopy; Visual Acuity; Vitreous Body | 2021 |
Occurrence, virulence genes, and antimicrobial profiles of Escherichia coli O157 isolated from ruminants slaughtered in Al Ain, United Arab Emirates.
Topics: Animals; Anti-Bacterial Agents; Camelus; Cattle; Cefotaxime; Chloramphenicol; Ciprofloxacin; Escherichia coli Infections; Escherichia coli Proteins; Feces; Female; Food Microbiology; Goats; Male; Microbial Sensitivity Tests; Norfloxacin; Polymyxin B; Prevalence; Ruminants; Sheep; Shiga-Toxigenic Escherichia coli; United Arab Emirates; Virulence Factors | 2020 |
Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics.
Topics: Anti-Bacterial Agents; Antioxidants; beta-Galactosidase; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Kanamycin; Oxidative Stress; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Streptomycin; Stress, Physiological | 2020 |
Cluster analysis of resistance combinations in Escherichia coli from different human and animal populations in Germany 2014-2017.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Cluster Analysis; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Germany; Humans; Microbial Sensitivity Tests; Poultry; Swine | 2021 |
Seven-year surveillance of the prevalence of antimicrobial-resistant Escherichia coli isolates, with a focus on ST131 clones, among healthy people in Osaka, Japan.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cefotaxime; Ciprofloxacin; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Humans; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence | 2021 |
CE-DAD-MS/MS in the simultaneous determination and identification of selected antibiotic drugs and their metabolites in human urine samples.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Clindamycin; Electrophoresis, Capillary; Humans; Linezolid; Metronidazole; Tandem Mass Spectrometry | 2022 |
Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Imipenem; Plasmids; Proteome; Proteomics | 2022 |
Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Humans; Liver Cirrhosis; Liver Failure | 2022 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
[Molecular characteristics of ciprofloxacin-cefotaxime-azithromycin co-resistant
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Quinolones; Salmonella; Salmonella enterica; Serogroup | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
In vitro and in vivo evaluation of DNase I in reinstating antibiotic efficacy against Klebsiella pneumoniae biofilms.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Cattle; Cefotaxime; Ciprofloxacin; Deoxyribonuclease I; Disease Models, Animal; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2023 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Antimicrobial resistance profiles of Campylobacter jejuni and Salmonella spp. isolated from enteritis patients in Japan.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Enteritis; Japan; Microbial Sensitivity Tests; Salmonella; Tetracycline | 2023 |
High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Iran; Phylogeny; Prevalence; Urinary Tract Infections | 2023 |
Microplastics accumulate priority antibiotic-resistant pathogens: Evidence from the riverine plastisphere.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microplastics; Plastics; Wastewater; Water | 2023 |
Genomic surveillance of antimicrobial-resistant Escherichia coli in fecal sludge and sewage in Uganda.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Genomics; Humans; Microbial Sensitivity Tests; Plasmids; Sewage; Uganda; Wastewater; Wastewater-Based Epidemiological Monitoring | 2024 |